Emerging research suggests that GLP-1RAs may also be beneficial in treating conditions like obstructive sleep apnea (Malhotra et al., 2024), osteoarthritis (Bliddal et al., 2024), metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis with liver fibrosis (MASH) (Loomba et al., 2024), polycystic ovary syndrome (PCOS) (Szczesnowicz et al., 2023), Alzheimers disease (Liang et al., 2024), Parkinsons disease (Kalinderi et al., 2024), and addiction (Klausen et al., 2022)
doi: 10.1371/journal.pone.0096863 85 MuscelliEMariACasolaroACamastraSSeghieriGGastaldelliAet al
To keep it simple, we want you to know that opioids interfere with your systems natural processes
At En Vogue IV Therapy & Wellness, our healthcare providers use BMI as a key screening tool to identify which patients will benefit most from treatments like tirzepatide
However, there are factors that remain unclear such as detailed mechanisms of IGF-1 regulation by SCFAs and the continuous control of SCFA levels in humans
Markers studied in trials Body weight - weekly or monthly trend, not daily
